Literature DB >> 7877834

Pulmonary immune responses to Nippostrongylus brasiliensis: isotype-specific antibodies in bronchoalveolar lavage fluids of rats.

K Ramaswamy1, D Befus.   

Abstract

Larvae of Nippostrongylus brasiliensis have an obligatory migratory phase through the lungs of rats during their development. Since earlier studies have shown that this migration is associated with accumulation of Fc receptor bearing effector cells in the bronchoalveolar spaces, we have analysed antibody reactivity in bronchoalveolar lavage fluids (BALF) during development of immune responses against N. brasiliensis. The development of parasite specific antibodies in bronchoalveolar spaces was similar to that in the serum, but was of a lower titre. A secondary infection resulted in an anamnestic response. Isotype analysis showed that IgG, IgA and IgM antibodies were present in BALF and they recognized several proteins of the parasite ranging from 16-290 kDa. Immunoblot analysis on two-dimensional electrophoretic separated parasitic proteins identified stage specific differences in the BALF antibody responses. IgG was the predominant class of antibody in BALF and when compared with serum, IgM antibody responses were weak. Thus, infection with N. brasiliensis resulted in the appearance of site-, stage- and isotype-specific antibody responses in the lungs of rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7877834     DOI: 10.1111/pim.1993.15.10.573

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  2 in total

1.  Immunoglobulin A response in murine schistosomiasis: stimulatory role of egg antigens.

Authors:  O Poulain-Godefroy; S Gaubert; S Lafitte; A Capron; J M Grzych
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

2.  γδ T Lymphocytes Coordinate Eosinophil Influx during Allergic Responses.

Authors:  Maria Das Graças Muller de Oliveira Henriques; Carmen Penido
Journal:  Front Pharmacol       Date:  2012-12-03       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.